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The anti-contractile effect of perivascular adipose tissue (PVAT) is an important
mechanism in the modulation of vascular tone in peripheral arteries. Recent evidence
has implicated the XE991-sensitive voltage-gated KV (KCNQ) channels in the regulation
of arterial tone by PVAT. However, until now the in vivo pharmacology of the involved
vascular KV channels with regard to XE991 remains undetermined, since XE991 effects
may involve Ca2+ activated BKCa channels and/or voltage-dependent KV1.5 channels
sensitive to diphenyl phosphine oxide-1 (DPO-1). In this study, we tested whether KV1.5
channels are involved in the control of mesenteric arterial tone and its regulation by
PVAT. Our study was also aimed at extending our current knowledge on the in situ
vascular pharmacology of DPO-1 and XE991 regarding KV1.5 and BKCa channels, in
helping to identify the nature of K+ channels that could contribute to PVAT-mediated
relaxation. XE991 at 30µM reduced the anti-contractile response of PVAT, but had no
effects on vasocontraction induced by phenylephrine (PE) in the absence of PVAT. Similar
effects were observed for XE991 at 0.3µM, which is known to almost completely inhibit
mesenteric artery VSMC KV currents. 30µM XE991 did not affect BKCa currents in
VSMCs. Kcna5−/− arteries and wild-type arteries incubated with 1µM DPO-1 showed
normal vasocontractions in response to PE in the presence and absence of PVAT. KV
current density and inhibition by 30µM XE991 were normal in mesenteric artery VSMCs
isolated from Kcna5−/− mice. We conclude that KV channels are involved in the control
of arterial vascular tone by PVAT. These channels are present in VSMCs and very potently
inhibited by the KCNQ channel blocker XE991. BKCa channels and/or DPO-1 sensitive
KV1.5 channels in VSMCs are not the downstream mediators of the XE991 effects on
PVAT-dependent arterial vasorelaxation. Further studies will need to be undertaken to
examine the role of other KV channels in the phenomenon.
Keywords: XE991, KCNQ channels, KV1.5 channels, adipocyte-derived relaxing factor (ADRF), perivascular
adipose tissue (PVAT), BK channels
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INTRODUCTION
Over the past decade, various potassium (K+) channels have
been implicated as important players in the regulation of arterial
vascular tone and its control by perivascular adipose tissue
(PVAT). Opening of vascular smooth muscle cell (VSMC) K+
channels causes K+ eﬄux and membrane hyperpolarization,
which leads to reduced Ca2+ influx though L-type CaV1.2
channels and consequently arterial relaxation (Nelson and
Quayle, 1995). A variety of endogenous vasodilators, such as
hypoxia, acidosis, as well as metabolites and autacoids (e.g.,
adenosine, prostacyclin) act as potent K+ channel openers to
produce relaxation (Sobey, 2001; Tano and Gollasch, 2014).
Noteworthy, many of these substances produce relaxation by
opening maxi Ca2+ activated (BKCa) K
+ channels in VSMCs
(Bentzen et al., 2014). Only very few substances have been
reported to relax vessels by opening arterial smooth muscle
voltage-gated KV channels (Tanaka et al., 2006; Park et al., 2015).
Among them adenosine and atrial natriuretic peptide (ANP) act
via activation of the KCNQ (KV7) subfamily of KV channels
(Khanamiri et al., 2013; Stott et al., 2015).
Recent studies have demonstrated a paracrine role for PVAT
to produce relaxation of arterial smooth muscle cells in a number
of vascular beds (Lohn et al., 2002; Verlohren et al., 2004; Gao
et al., 2005; Zavaritskaya et al., 2013). Certain adipokines, such as
adiponectin (Weston et al., 2013), angiotensin-1 to 7 (Lee R. M.
K. W. et al., 2011), methyl palmitate (Lee Y.-C. et al., 2011), and
notably H2S (Schleifenbaum et al., 2010) were recently proposed
as potential perivascular-derived relaxing factors (PVRFs), which
could mediate the anti-contractile properties of PVAT. The
paracrine effects of PVAT involve the opening of K+ channels,
however, the identity of the K+ channel subtype(s) involved is
still a matter of debate (Tano et al., 2014).
Voltage-gated KV channels of the KCNQ (KV7) family have
been proposed to play an important role in PVAT control
of arterial tone. This conclusion is based on observations
demonstrating that the anti-contractile effects of PVAT are
inhibited by the pan KCNQ channel blocker XE991 at 30µM
or the pan KV channel blocker 4-aminopyridine (2mmol/L;
Fésüs et al., 2007; Schleifenbaum et al., 2010; Lee Y.-C. et al.,
2011; Zavaritskaya et al., 2013). XE991 is a widely used
pan KV7 channel blocker, which inhibits KV7.1 homomeric
or KV7.1/KCNE channels (IC50 of ∼0.8µM and 11.1µM,
respectively; Wang et al., 2000), KCNQ2/3 channels (EC50
∼1µM; Wang et al., 1998), KCNQ4 (EC50 ∼5.5µM; Søgaard
et al., 2001), and KCNQ5 (EC50 ∼65µM; Schroeder et al.,
2000). Noteworthy, XE991 can also inhibit other KV channels,
such as ERG (KV11; EC50 ∼110µM) (Elmedyb et al., 2007) and
KV1.2/1.5, KV2.1/KV9.3 channels (∼30% inhibition at 10µM) in
heterologous expression systems (Zhong et al., 2010).
However, it is unknown whether XE991 is indeed specific
for vascular KV channels in situ, and does not inhibit native
BKCa channels. This is particularly relevant since BKCa channels
have been proposed to play a role in PVAT control of arterial
tone in other studies (Lynch et al., 2013; Weston et al., 2013),
although studies using BKCa deficient mice gave opposing results
(Fésüs et al., 2007). A recent study showed that KV channels in
VSMCs of mouse mesenteric arteries are very sensitive to XE991
(EC50 ∼60 nM), suggesting that these channels may contribute to
PVAT control of arterial tone (Schleifenbaum et al., 2010, 2014).
A very recent study suggested that diphenyl phosphine oxide-
1 (DPO-1) sensitive KV1.5 channels could contribute to the KV
current in VSMC (Fancher et al., 2015).
Therefore, we tested whether KV1.5 channels are involved in
the control of arterial tone and its regulation by PVAT or not.
Our study is also aimed at extending our current knowledge on
the in situ vascular pharmacology of DPO-1 and XE991 regarding
KV1.5 and BKCa channels, in helping to identify the nature of K
+
channels that could contribute to PVAT-mediated relaxation.
METHODS
Mouse Model
We usedKcna5−/−mice as previously described (Pannasch et al.,
2006). The mouse model was evaluated by RT-qPCR (Figure
S1). Either litter- or age-matched (10–14 weeks old) male wild-
type (129S6 background, previously known as 129SvEv-Ta) mice
were used as controls. 250–300 g male Sprague Dawley rats were
obtained from Charles River, Germany, Berlin. All experimental
procedures were performed in accordance with the German
legislation on protection of animals. Animal care followed
American Physiological Society guidelines, and local authorities
(Landesamt für Gesundheit und Soziales Berlin, LAGeSo)
approved all protocols. Mice were housed in individually
ventilated cages under standardized conditions with an artificial
12-h dark–light cycle with free access to water and food.
Wire Myography
First order mesenteric arteries were removed immediately after
killing the mice or rats under inhalation anesthesia with
isoflurane by cervical dislocation, quickly transferred to cold
(4◦C), oxygenated (95% O2/5% CO2) physiological salt solution
(PSS) containing (in mmol/L) 119 NaCl, 4.7 KCl, 1.2 KH2PO4,
25 NaHCO3, 1.2 MgSO4, 11.1 glucose, 1.6 CaCl2), and dissected
into 2mm rings whereby perivascular fat and connective tissue
were either intact [(+) PVAT or removed (−) PVAT] without
damaging the adventitia. Each ring was positioned on two
stainless steel wires (diameter 0.0394mm) in a 5-ml organ bath
of a Mulvany Small Vessel Myograph (DMT 610 M; Danish Myo
Technology, Denmark). The organ bath was filled with PSS. The
bath solution was continuously oxygenated with a gas mixture of
95%O2 and 5% CO2, and kept at 37
◦C (pH 7.4) (Verlohren et al.,
2004; Fésüs et al., 2007). The mesenteric rings were placed under
a tension equivalent to that generated at 0.9 times the diameter of
the vessel at 100mm Hg by stepwise distending the vessel using
LabChart DMT Normalization module. This normalization
procedure was performed to obtain the passive diameter of the
vessel at 100mm Hg (Fésüs et al., 2007). The software Chart5
(AD Instruments Ltd. Spechbach, Germany) was used for data
acquisition and display. After 60min equilibration arteries were
pre-contracted either with isotonic external 60mmol/L KCl until
a stable resting tension was acquired. The composition of 60mM
KCl (in mmol/L) was 63.7 NaCl, 60 KCl, 1.2 KH2PO4, 25
NaHCO3, 1.2Mg2SO4, 11.1 glucose, and 1.6 CaCl2. Drugs were
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added to the bath solution if not indicated otherwise. Tension
is expressed as a percentage of the steady-state tension (100%)
obtained with isotonic external 60mM KCl.
Isolation of Arterial VSMCs
VSMCs from mesenteric arteries were isolated as described
(Gollasch et al., 1998; Plüger et al., 2000). Briefly, the arteries were
isolated and quickly transferred to cold (4◦C) oxygenated (95%
O2–5% CO2) PSS. The arteries were cleaned, cut into pieces, and
placed into a Ca2+-free Hank’s solution (in mmol/L): 55 NaCl,
80 sodium glutamate, 5.6 KCl, 2 MgCl2, 1mg/ml bovine serum
albumin (BSA, Sigma, Taufkirchen), 10 glucose, and 10 HEPES
(pH 7.4 with NaOH) containing 0.5mg/ml papain (Sigma) and
1.0mg/ml DTT for 50min at 37◦C. The segments then were
placed in Hank’s solution containing 1mg/ml collagenase (Sigma,
type F and H, ratio 30 and 70%, respectively) and 0.1mmol/L
CaCl2 for 10min at 37
◦C. Following several washes in Ca2+-
free Hank’s solution (containing 1mg/ml BSA), single cells were
dispersed from artery segments by gentle triturating. Cells were
then stored in the same solution at 4◦C.
Electrophysiology
Voltage dependent potassium (KV) currents and BKCa currents
were measured in the conventional whole-cell configuration of
the patch-clamp technique at room temperature as previously
described (Gollasch et al., 1996; Essin et al., 2007; Schleifenbaum
et al., 2014). Patch pipettes (resistance 3–5 M) for recording
KV currents were filled with a solution containing (in mmol/L):
130 KCl, 1 MgCl2, 3 Na2ATP, 0.1 Na3GTP, 10 HEPES, and 5
EGTA (pH 7.2; Yeung and Greenwood, 2005). Patch pipettes
for recording BKCa currents contained (in mmol/L): 130 KCl,
1 MgCl2, 3 Na2ATP, 0.1 Na3GTP, 10 HEPES, 5 EGTA, and
4.3 CaCl2 (estimated [Ca
2+] free, 10−6 mol/L; pH 7.2). The
external bath solution contained (in mmol/L): 126 NaCl, 5 KCl, 1
MgCl2, 0.1 CaCl2, 11 glucose and 10 HEPES (pH 7.2; Yeung and
Greenwood, 2005). Holding potential was −60mV. Whole cell
currents were recorded using an Axopatch 200B amplifier (Axon
Instruments/Molecular Devices, Sunnyvale, CA, USA) or an EPC
7 amplifier (List, Darmstadt, Germany) and digitized at 5 kHz,
using a Digidata 1440A digitizer (Axon CNS,Molecular Devices),
and pClamp software versions 10.1 and 10.2 (Schleifenbaum
et al., 2014).
RT-qPCR
Total RNA was isolated from snap-frozen heart and aortae
tissues with or without KV1.5 by using the RNeasy RNA
isolation kit (Qiagen, Hamburg, Germany) according to
the manufacturer’s instruction. Isolated RNA concentration
was measured and RNA quality was tested by NanoDrop-
1000 spectrophotometer (PeqLab, Erlangen, Germany). For
the synthesis of cDNA, equivalent amounts of RNA (2µg)
were used and processed by a high capacity cDNA reverse
transcription kit (Life Technologies GmbH, Darmstadt,
Germany). Quantitative analysis of target mRNA expression
was performed with real-time PCR using the relative standard
curve method (Markó et al., 2016). TaqMan or SYBR green
analysis was conducted according to the manufacturer’s
instructions, using an Applied Biosystems 7500 Sequence
Detector (Life Technologies Corporation, Carlsbad, CA, USA).
The expression level of the target genes was normalized by
the expression of 18S. Primers for were synthesized by Biotez
(Berlin, Germany) and the sequences are as follows: KV1.5
Forward sequence: 5′-GCTACTTCGATCCCTTGAGAAAT-3′;
Reverse sequence: AGTAGTACAAAATGCCATCGAAGCT,
18S Forward sequence: 5′-ACATCCAAGGAAGGCAGCAG-3′;
Reverse sequence 5′-TTTTCGTCACTACCTCCCCG-3′.
Materials
All salts and other chemicals were obtained from Sigma-Aldrich
(Germany) orMerck (Germany). All drugs were freshly dissolved
on the day of each experiment according to the material sheet.
The following concentrations of drugs were used: phenylephrine
(Sigma-Aldrich) ranged from 0.01 to 100µmol/L, 5-HT from
0.01 to 10µM, DPO-1 (Tocris) 1 and 10µmol/L, 100 nmol/L
iberiotoxin (Sigma Aldrich). XE991 (Tocris) was applied at
concentrations between 0.3 and 30µM.
Statistics
Data represent mean ± SEM. EC50 values were calculated using
a Hill equation: T= (B0 − Be)/(1+ ([D]/EC50)
n)+ Be, where T
is the tension in response to the drug (D); Be is the maximum
response induced by the drug; B0 is a constant; EC50 is the
concentration of the drug that elicits a half-maximal response
(Bychkov et al., 1998). Curve fittings were done by Prism 6
software using non-linear regression. Statistical significance was
determined by two-way ANOVA or repeated-measures two-way
ANOVA, followed by Bonferroni post hoc test, and using Prism 6
software. In case of unbalanced data, this software uses analysis
of “unweightedmeans” to compare groups. Extra sum-of-squares
F-test was performed for comparison of concentration-response
curves and their 95% confidence intervals (CI). P-values < 0.05
were considered statistically significant. n represents the number
of independent arteries tested or the number of cells measured.
All rings were obtained from at least 3 different animals.
RESULTS
Regulation of Arterial Tone by DPO-1
Sensitive KV1.5 Channels
First, we examined the role of KV1.5 channels in the regulation of
arterial tone by alpha1 adrenoceptor (alpha1-AR) stimulation. In
this set of experiments, we used the KV1.5 channel blocker DPO-
1 at concentrations assumed to be specific and potent for KV1.5
channel inhibition (Stump et al., 2005; Lagrutta et al., 2006; Regan
et al., 2006). In the presence of 1µM DPO-1, mesenteric artery
rings without PVAT [(−) PVAT] displayed similar contractions
in response to phenylephrine (PE) compared to non-treated
(−) PVAT control rings (Figures 1A,B). The 95% CI for EC50
of control and DPO-1 treated rings were 1.21–1.79µM and
0.78–1.40µM, respectively. The anti-contractile effects of PVAT
were also unchanged by 1µM DPO-1: the 95% CI for EC50 of
control (+) PVAT and 1µM DPO-1 (+) PVAT treated rings
were 3.99–8.14µM and 4.99–10.05µM, respectively. To further
confirm the results obtained with the KV1.5 channel inhibitor,
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we performed similar experiments using mesenteric artery rings
from Kcna5−/− mice. PE induced vasocontractions in (−) PVAT
Kcna5−/− rings were not different from those observed in (−)
PVATKcna5+/+ rings (Figures 1C,D). Similarly, we observed PE
induced vasocontractions in (+) PVAT Kcna5−/− rings, which
were not different from those observed in (+) PVAT Kcna5+/+
rings (Figures 1C,D). The 95% CI for EC50 of (−) PVAT and (+)
PVAT arteries isolated from Kcna5−/− mice were 0.81–1.30µM
FIGURE 1 | Effects of pharmacological blockade and genetic deletion
of KV1.5 channels on regulation of arterial tone by perivascular
adipose tissue (PVAT), phenylephrine (PE), and serotonin (5-HT). (A)
Original traces showing the effects of 1µM DPO-1 on PE-induced
contractions in (−) PVAT and (+) PVAT mesenteric artery rings compared with
control rings without DPO-1. (B) Concentration-response relationships for
PE-induced contractions in Kcna5+/+ (+) PVAT (n = 8) or (−) PVAT (n = 9)
mesenteric arteries in the absence of DPO-1 or in Kcna5+/+ (+) PVAT (n = 8)
and (−) PVAT (n = 9) arteries after 30min of pre-incubation with 1µM DPO-1.
*p < 0.05, for (−) PVAT vs. (+) PVAT or (−) PVAT + DPO-1 vs. (+) PVAT +
DPO-1; repeated-measures two-way ANOVA, followed by Bonferroni post hoc
test. (C) Original traces showing the effects of genetic deletion of Kcna5 on
PE-induced contractions in (−) PVAT and (+) PVAT mesenteric artery rings. (D)
PE-induced contractions of (+) PVAT and (−) PVAT artery rings isolated from
Kcna5+/+ [(+) PVAT, n = 8; (−) PVAT, n = 9] and Kcna5−/− [(+) PVAT,
n = 12; (−) PVAT, n = 12] mice. *p < 0.05, for (−) PVAT Kcna5+/+ vs. (+)
PVAT Kcna5+/+ or (−) PVAT Kcna5−/− vs. (+) PVAT Kcna5−/−. (E)
Cumulative concentration-response relationships to 5-HT in (+) PVAT (n = 7)
and (−) PVAT rat mesenteric arteries (n = 6) and the effects of 1µM DPO-1 on
(+) PVAT (n = 6) and (−) PVAT rat mesenteric arteries (n = 8). *p < 0.05, for
(−) PVAT vs. (+) PVAT or (−) PVAT + DPO-1 vs. (+) PVAT + DPO-1;
repeated-measures two-way ANOVA, followed by Bonferroni post hoc test.
and 4.94–7.79µM, respectively. Data are summarized in Table 1.
Experiments on rat mesenteric arteries showed similar results:
Cumulative dose-response curves in response to serotonin (5-
HT) were similar in vessel rings in the absence or presence
of DPO-1 (Figure 1E). Together, the results suggest that KV1.5
channels do not play a functionally relevant role in the control of
arterial tone by PVAT, α1-AR and 5-HT agonists, in both mouse
and rat mesenteric arteries.
DPO-1 Sensitive KV Channels Distinct from
KV1.5 May Regulate Arterial Tone
Next, we studied putative non-KV1.5 channel dependent
effects by using higher concentrations of DPO-1. Figure 2A
shows that 1µM DPO-1 had no effects on basal tone of
Kcna5+/+ mesenteric artery rings with and without PVAT.
Surprisingly, application of 10µM DPO-1 resulted in a stable
contraction of Kcna5+/+ mesenteric arteries without but not
with PVAT (Figure 2B). This effect remained stable over 30min
and was observed also on rings isolated from Kcna5−/−
mice (Figure 2C). Thus, unexpectedly, inhibition of DPO-
1 sensitive KV channels distinct from KV1.5 channels or
other pathways could contribute to vascular tone in this
preparation.
Effects of XE991 on KV Currents, BKCa
Currents and the Anti-Contractile Effects
of PVAT
KV currents were recorded in mesenteric artery VSMCs freshly
isolated fromKcna5+/+ andKcna5−/−mice.We did not observe
any difference between KV current densities in Kcna5
+/+ and
Kcna5−/− VSMCs. Moreover, KV current inhibition by 30µM
XE991 was not different between Kcna5+/+ and Kcna5−/−
VSMCs (Figures 3A,B). 30µM XE991 did not affect basal
tone of mesenteric arteries prepared with or without PVAT
(Figure S2).
In order to better understand the effects of XE991, we tested its
actions on BKCa currents, potential mediators of the PVAT effect.
VSMC Kcna5+/+ BKCa currents were recorded in the absence
and presence of 30µM XE991. 100 nM iberiotoxin (a potent and
highly selective BKCa channel inhibitor) was used as positive
control. While 30µM XE991 did not affect the BKCa current,
iberiotoxin almost completely inhibited the BKCa current. These
results are consistent with plasma membrane VSMC BKCa
channel activity resistant to XE991 in situ, at concentrations up
to 30µM of XE991 (Figures 3C,D).
Additionally, we tested the effects of 30µM and 0.3µM
XE991 on the paracrine effects of PVAT on arterial tone. We
found that XE991 even at the low concentration abolished
the anti-contractile effects of PVAT. Interestingly, application
of 0.3 and 30µM XE991 resulted in a similar reduction of
the anti-contractile effects of PVAT (Figures 4A,B). The EC50
95% CI values were 1.92–3.09 and 1.32–2.02µM for (+) PVAT
rings preincubated with 0.3µM XE991 and 30µM XE991,
respectively; and 4.18–5.84µM for (+) PVAT rings in the absence
of XE991. (−) PVAT rings showed no difference, regardless
of the absence or presence of 0.3µM or 30µM XE991. Data
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TABLE 1 | EC50 and its confidence intervals.
Condition Mouse background Without PVAT With PVAT
EC50 µM 95% confidence interval (CI) n EC50 µM 95% confidence intervals (CI) n
Kcna5+/+ 129SVE-M 1.48 1.21–1.79 9 5.72 3.99–8.14 8
Kcna5 −/− 129SVE-M 1.02 0.81–1.30 10 6.20 4.94–7.79 12
Kcna5+/+ +1µM DPO-1 129SVE-M 1.04 0.78–1.40 11 7.24 4.99–10.05 11
Control C57BL/6 0.70 0.57–0.87 17 4.94 4.18–5.84 21
0.3µM XE991 C57BL/6 0.48 0.30–0.75 5 2.43 1.92–3.09 13
30µM XE991 C57BL/6 0.38 0.24–0.65 5 1.64 1.32–2.02 12
Data calculated from concentration-response curves to phenylephrine after normalization to maximum response from within each curve. For comparison of data and groups, see text
and figures.
FIGURE 2 | Effects of 1µM and 10µM DPO-1 on basal arterial tone of
mesenteric artery rings isolated from Kcna5+/+ and Kcna5 −/− mice.
Original traces showing contraction of mesenteric (−) and (+) PVAT rings
induced by 60mmol/L KCl and by 1µM (A) and 10µM DPO-1 (B). (C) Vessel
tension induced by 10µM DPO-1. Tension is expressed as a percentage of
KCl contractions. Kcna5+/+ (−) PVAT, n = 9; (+) PVAT, n = 13. Kcna5−/− (−)
PVAT, n = 7; (+) PVAT, n = 9. *p < 0.05, two-way ANOVA followed by
Bonferroni post hoc test.
are presented in Table 1. Together, our data demonstrate that
XE991 is a potent inhibitor of PVAT control of arterial tone
at low concentrations similar to its potency of inhibiting KV
currents in VSMCs (Schleifenbaum et al., 2014). BKCa channels
are however exempt from this inhibitory effect of XE991 (up to
30µM).
DISCUSSION
Perivascular adipose tissue plays a potent anti-contractile role
in the control of arterial tone along arterial segments of
different vascular beds and species. The main findings of this
study are threefold. First, XE991 inhibits the PVAT effect
at nanomolar concentrations in mesenteric arteries of mice.
Interestingly, similar concentrations were found in earlier studies
to inhibit VSMC KV currents (50% inhibition at 60 nM XE991)
(Schleifenbaum et al., 2014). Second, Kcna5−/− mice exhibited
normal VSMC KV currents and arterial contractions in the
absence and presence of PVAT, whose effects were insensitive
to DPO-1. Third, the KCNQ channel blocker XE991 does not
affect plasmamembrane VSMCBKCa channels at concentrations,
which inhibit the anti-contractile effects of PVAT. Together,
the results of our current study implicate KCNQ-type KV
channels in the XE991-mediated inhibition of the PVAT effects.
Simultaneously, we exclude BKCa as well as KV1.5 channels as
potential downstream candidates in this process.
KV1.5 in Regulation of Arterial Tone
In recent studies, KV1.5 channels have been shown to
determine microvascular tone and the arteriolar response to
vasoconstrictors in rat cerebral arteries (Chen et al., 2006;
Fancher et al., 2015). Furthermore, KV1.5 channels in the heart
are essential in coupling myocardial blood flow to cardiac
metabolism (Ohanyan et al., 2015). Moreover, hypertension is
associated with altered expression of vascular KV1.5 channels
(Wang et al., 1997; Platoshyn et al., 2001; Cox and Rusch,
2002; Cox et al., 2008; Cidad et al., 2014). Therefore, KV1.5
channels may represent interesting putative targets of PVAT
and that raised the question of their potential involvement
in the regulation of arterial tone by phenylephrine in mouse
mesenteric arteries. Our results suggest that KV1.5 channels
are however not involved. In effect, the anti-contractile effects
of PVAT were not different between Kcna5−/− and Kcna5+/+
arteries. Additionally, the KV1.5 channel inhibitor DPO-1 at
1µM displayed no effect on vasocontractions in the absence and
presence of PVAT. Notably, the mechanism of DPO-1 action
(“open channel” blocker) might be a potential confounding
factor, since KV1.5 channels are activated at V0.5 of −14mV
(Grissmer et al., 1994). However, the genetic approach had the
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FIGURE 3 | Voltage dependent (KV) K
+ currents and BKCa currents in freshly-isolated mesenteric artery vascular smooth muscle cells (VSMCs) from
Kcna5−/− and Kcna5+/+ mice. KV currents before (−XE991) and after (+XE991) application of 30µM XE991. Current densities of peak KV currents (A) (n = 6
Kcna5−/− cells, n = 10 Kcna5+/+ cells, before and after application of XE991, respectively); original recordings (B). (C) Relative inhibition of peak BKCa current by
iberiotoxion (IbTx) at 100 nM (n = 5) and XE991 at 30µM (n = 9) in Kcna5+/+ VSMCs, original recordings are represented in (D).
advantage to study vascular effects in the absence of KV1.5
channels avoiding possible confounders related to membrane
potential-dependent drug mechanisms. Furthermore, we did
not observe any significant differences in the KV current
density and inhibition by XE991 in Kcna5−/− and Kcna5+/+
VSMCs. Therefore, we conclude that KV1.5 channels have no
apparent role in PVAT-dependent relaxation and are not the
XE991 sensitive channels that contribute to this process. This
conclusion is in line with our previous results obtained on
cloned and heterologously expressed KV1.5 alpha subunits in
HEK293 cells (Schleifenbaum et al., 2014). In these experiments,
100 nM XE991 failed to block KV1.5 currents. We also observed
similar responses of arterial rings without PVAT to PE and 5-
HT, regardless of genetic deletion of KV1.5 alpha subunits or
pharmacological blockade of KV1.5 channels by DPO-1. To our
knowledge, this is the first study to firmly establish that KV1.5
channels are not involved in the regulation of arterial tone of
systemic visceral arteries of mice and rats, at least in mesenteric
arteries. Our conclusions substantiate the work of other groups,
namely that patients with genetic mutations of KCNA5 exhibit
pulmonary arterial hypertension and arterial fibrillation but
not systemic hypertension (Yang et al., 2009; Wipff et al.,
2010; Machado et al., 2015). Together, our data questions the
contribution of KV1.5 channels in a number of small resistance
arteries to peripheral arterial resistance. The findings are however
not generalizable to all vascular beds as KV1.5 channels were
demonstrated to play important vasoregulatory functions in
cerebral arteries and in Gracilis skeletal muscle arteries (Chen
et al., 2006; Fancher et al., 2015).
DPO-1 Sensitive K+ Channels and
Pathways Distinct from KV1.5 Involved in
Regulation of Arterial Tone
DPO-1 was described as a specific KV1.5 inhibitor at micromolar
concentrations (Stump et al., 2005; Lagrutta et al., 2006; Regan
et al., 2006). It exerts its inhibitory effects through binding
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FIGURE 4 | Effects of XE991 on regulation of arterial tone by
perivascular adipose tissue. Cumulative concentration-response curves to
PE in the presence of 30µM XE991 (A) and 0.3µM XE991 (B), expressed as
a percentage of KCl contractions. (−) PVAT, n = 17; (+) PVAT, n = 21. (+)
PVAT (+) 30µM XE991, n = 12; (+) PVAT + 0.3µM XE991, n = 13; (−) PVAT
(+) 30µM XE991, n = 5; (−) PVAT + 0.3µM XE991, n = 5. *p < 0.05,
repeated-measures two-way ANOVA, followed by Bonferroni post hoc test * in
(A), (+) PVAT vs. (+) PVAT + 30µM XE991. *In (B), (+) PVAT vs. (+) PVAT +
0.3µM XE991. Experiments were performed on mouse mesenteric arteries.
with several key residues in the S5- pore loop-S6 domains, thus
resulting in blockade of the open state of the KV1.5 channel
(Karczewski et al., 2009; Du et al., 2010). Other studies have
suggested a DPO-1 preference for vascular KV1.5 channels,
though with limited selectivity (Fancher et al., 2015). In this
study, DPO-1 (1–10µM) inhibited the outward K+ current in
arterial smooth muscle cells from wild-type (Kcna5+/+) mice
and mice lacking the Kcna5 gene; however, the inhibitory effect
was much greater in cells from Kcna5+/+ mice (Fancher et al.,
2015). Subsequently, our data in Figure 2 suggests that 10µM
DPO-1 induces contractions by inhibiting channels distinct from
KV1.5 channels. Those channels appear to be important for the
regulation of resting arterial tone. Interestingly, DPO-1 is able
to block KV1.3 channel currents at EC50 of 3.1µM in human
T cells (Zhao et al., 2013). Kcna3 mRNA expression is also
observed in mouse mesenteric arteries (Fountain et al., 2004;
Cidad et al., 2014). Although the ability of KV1.5 and KV1.3 to
form heteromers (Kv1.5/Kv1.3) (Villalonga et al., 2007) impede
the study of their specific roles in native tissues in vivo, it is
intriguing to speculate that KV1.3 channels could represent a
putative target of PVAT regulation of arterial tone. Future studies
are necessary to clarify their role.
Effects of XE991 on KV channels, BKCa
Channels and Paracrine PVAT Effects
In the mouse mesenteric arteries, Kcnq1, Kcnq4, and Kcnq5
expression was demonstrated at the mRNA level (Yeung et al.,
2007), whereas mRNA expression of Kcnq2, Kcnq3 was not
detectable or only at borderline low levels (Yeung et al., 2007;
Schleifenbaum et al., 2014). We previously suggested that KCNQ
type KV channels are key players in the paracrine role for
periadventitial adipose tissue in the regulation of arterial tone
(Schleifenbaum et al., 2010; Zavaritskaya et al., 2013); based on
mRNA expression levels (see above), KCNQ1, KCNQ4, and/or
KCNQ5 channels are likely candidates. This suggestion is also
based on the ability of 30µM XE991 (pan KCNQ blocker) and
2mmol/L 4-aminopyridine (pan KV blocker) to block the anti-
contractile effects of PVAT. Interestingly, KCNQ channel openers
normalized reduced anti-contractile effects of PVAT in a rat
model of hypertension (Zavaritskaya et al., 2013), which suggests
therapeutic perspectives of KCNQ targeting in cardiovascular
disease. It is thus imperative to better understand the actions of
these compounds on the vasculature. In order to obtain more
information about the potency of XE991 inhibition on PVAT-
mediated anti-contractility, we performed experiments with a
100x lower concentration of XE991. The data show that this
considerably reduced concentration still exerted an inhibitory
impact on PVAT regulation of arterial tone (Figures 4A,B), while
basal tone was unaffected in rings (+) or (−) PVAT (Figure
S2). The incomplete inhibition observed, however suggests
the possible involvement of additional K+ channels in this
process. Furthermore, our data demonstrates that VSMC plasma
membrane BKCa channels are not involved in the effects of XE991
on PVAT regulation, since XE991 does not inhibit BKCa currents
(this study). This is in line with our previous findings indicating
that the paracrine effects of PVAT on arterial tone are normal in
the presence of BKCa channel blockers or in arteries that lack
BKCa beta1 channel subunits (Fésüs et al., 2007; Zavaritskaya
et al., 2013).
Previous studies examined the ability of XE991 to inhibit
heterologously expressed KV1.5 alpha subunits. We found that
100 nM and 30µM XE991 was unable to block monotetrameric
KV1.5 channels heterologously expressed in HEK293 or CHO
cells (Zavaritskaya et al., 2013; Schleifenbaum et al., 2014).
Interestingly, Zhong et al. found a small (∼20% at (+) 5mV)
inhibiting effect for 10µM XE991 on heterologously expressed
heterotetrameric KV1.2/KV1.5 and KV2.1/KV9.3 channel
subunits (Zhong et al., 2010). The block of KV1.2/KV1.5
channels was voltage dependent, and evident only at voltages
positive to -15mV. Our present study contributes to the
debate about the importance of accessory subunits for
determining the pharmacological properties of vascular K+
channels in vivo. Since regulatory KVbeta1.3 subunits can
decrease the sensitivity of KV1.5 channels to pharmacological
inhibitors such as DPO-1 (Gonzalez et al., 2002; Arias et al.,
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2007; Du et al., 2010), one could argue that DPO-1 is not
a reliable tool to study KV1.5 channels in native tissues.
However, we believe that our pharmacological approach
in combination with the Kcna5−/− mouse model firmly
demonstrates that the XE991 sensitive regulation of arterial
tone by PVAT regulation does not involve native vascular KV1.5
channels.
CONCLUSION
In conclusion, our results demonstrate that KV1.5 channels
are not involved in the control of mesenteric arterial tone
and its regulation by PVAT in mouse and rat mesenteric
arteries. The nature of the 10µM DPO-1 sensitive component
is unclear, but is most likely related to non-specificity of
this drug, for example in targeting vascular KV1.3 and/or
KCNQ channels in situ. Importantly, the inhibitory effects
of XE991 on PVAT vasorelaxation are rather related to
inhibition of KCNQ-type KV channels than BKCa channels.
These data unequivocally substantiate the hypothesis of different
targets of perivascular relaxing factor(s), which employ distinct
mechanisms to mediate an anti-contractile effect. Further studies
should focus on the enhancement of these relaxing factors,
as these will be beneficial for patients with cardiovascular
diseases.
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